derivados imidazo[1,2-a]piridina substituídos, composições farmacêuticas, e métodos de uso como inibidores da b-secretase

The present invention is directed to substituted imidazo[1,2-a]pyridine derivatives, pharmaceutically acceptable salts thereof, and tautomers of such compounds or salts, that inhibit -site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment of diseases in which B...

Full description

Saved in:
Bibliographic Details
Main Authors DEVI REDDY GOHIMUKKULA, BAPU GADDAM, TAN REN, RONGYUAN XIE, HASSAN EL ABDELLAOUI, ROBERT C. ANDREWS, ANITHA HARI, ADNAN M.M. MJALLI, DHARMA R. POLISETTI, MOHAN RAO
Format Patent
LanguagePortuguese
Published 29.03.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to substituted imidazo[1,2-a]pyridine derivatives, pharmaceutically acceptable salts thereof, and tautomers of such compounds or salts, that inhibit -site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment of diseases in which BACE is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which BACE is involved.
Bibliography:Application Number: BR2010PI12697